Molecular alterations in IDH 1/2 genes among Iraqi adult acute myeloid leukemia patients: Their response to treatment
BACKGROUND: The recurrent somatic variations in IDH1/2 genes in AML play imperative roles in epigenetic dysregulation and the pathogenesis of AML, which could be useful prognostic markers for risk stratification. AIM: The aim of the study was to detect the frequency of R132 mutations in the IDH1 ge...
Main Authors: | Haider Hasan Jaleel Al-Shammari, Haithem Ahmed Al-Rubaie, Ihsan Mardan Al-Badran |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Journal of Applied Hematology |
Subjects: | |
Online Access: | http://www.jahjournal.org/article.asp?issn=1658-5127;year=2023;volume=14;issue=2;spage=87;epage=94;aulast= |
Similar Items
-
The Molecular Mechanisms of Resistance to IDH Inhibitors in Acute Myeloid Leukemia
by: Xiaomei Zhuang, et al.
Published: (2022-06-01) -
Efficacy and safety of FDA-approved IDH inhibitors in the treatment of IDH mutated acute myeloid leukemia: a systematic review and meta-analysis
by: Xiu Chen, et al.
Published: (2023-07-01) -
Venetoclax-Azacitidine Bridging PTCy-haplo-PBSCT for Refractory Acute Myeloid Leukemia with IDH2 Mutations
by: Yusuke Daido, et al.
Published: (2023-09-01) -
Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: a systematic review and meta-analysis
by: Yao Qin, et al.
Published: (2023-06-01) -
Clinical characteristics and prognostic significance of DNA methylation regulatory gene mutations in acute myeloid leukemia
by: Xiaoyan Xu, et al.
Published: (2023-03-01)